Verastem, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $30.9M | $10.0M | — | $2.6M | $2.1M |
| Operating income | -$170.1M | -$115.0M | -$92.1M | -$72.9M | -$61.4M |
| Cash from operations | -$137.5M | -$104.8M | -$86.5M | -$63.7M | -$53.5M |
| Capital expenditure | — | $28,000 | $7,000 | — | $196,000 |
| Free cash flow | — | -$104.8M | -$86.5M | — | -$53.7M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $246.4M | $101.5M | $149.7M | $95.0M | $108.7M |
| Total liabilities | $189.2M | $130.4M | $71.2M | $47.7M | $21.1M |
| Total debt | — | $40.0M | $40.0M | $25.0M | — |
Shares outstanding 87.9M · Free float 96.9%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.